2023 annual financial data
Enliven Therapeutics 2023 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -83.53M USD and net income was -71.58M USD.
Operating cash flow was -61.27M USD.
Get free Enliven Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -83.53M USD
- Net income
- -71.58M USD
- Operating cash flow
- -61.27M USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Enliven Therapeutics financial years